# FDA Inspection 1135746 - Filipa Lynce, M.D. - January 29, 2021

Source: https://www.keypedia.com/records/fda_inspections/filipa-lynce-md/6c3847eb-3bee-4693-a68a-67c64b8b1bc1
Source feed: FDA_Inspections

> FDA Inspection 1135746 for Filipa Lynce, M.D. on January 29, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1135746
- Company Name: Filipa Lynce, M.D.
- Inspection Date: 2021-01-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1287944 - 2025-10-21](https://www.keypedia.com/records/fda_inspections/filipa-lynce-md/54276b1a-0cc1-4a74-9f0a-b9bc1f647c9d)

Company: https://www.keypedia.com/companies/filipa-lynce-md/8bfcb49f-49c9-456a-8449-5bbec827b8e6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c